Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 15/20 | 0.74 |
| ▸ | MEN1 | O00255 | 8/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.74 |
| ▸ | RAB9A | P51151 | 4/20 | 0.74 |
| ▸ | GAA | P10253 | 2/20 | 0.72 |
| ▸ | LMNA | P02545 | 1/20 | 0.72 |
| ▸ | RXFP1 | Q9HBX9 | 5/20 | 0.71 |
| ▸ | POLB | P06746 | 4/20 | 0.69 |
| ▸ | MMP2 | P08253 | 1/20 | 0.68 |
| ▸ | MMP9 | P14780 | 1/20 | 0.68 |
| ▸ | MMP8 | P22894 | 1/20 | 0.68 |
| ▸ | MMP13 | P45452 | 1/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.68 |
| ▸ | NPC1 | O15118 | 3/20 | 0.68 |
| ▸ | HPGD | P15428 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | EGFR | P00533 | 1/20 | 0.64 |
| ▸ | INSR | P06213 | 1/20 | 0.64 |
| ▸ | IGF1R | P08069 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12963182 | 0.92 | MAPT (0.83) | MAPTMEN1KMT2AKDM4ERAB9A | |
| SCHEMBL12980262 | 0.91 | MAPT (0.69) | MAPTMEN1KMT2AKDM4ERAB9A | |
| SCHEMBL16602315 | 0.91 | MAPT (0.72) | MAPTMEN1KMT2AKDM4ERAB9A | |
| SCHEMBL12963178 | 0.89 | MAPT (0.66) | MAPTMEN1KMT2AKDM4ERAB9A | |
| SCHEMBL12963448 | 0.88 | EGFR (0.70) | MAPTMEN1KMT2AKDM4ERAB9A | |
| SCHEMBL12980314 | 0.87 | EGFR (0.84) | MAPTMEN1KMT2AKDM4ERAB9A | |
| SCHEMBL2245625 | 0.87 | MAPT (0.76) | MAPTMEN1KMT2AKDM4ERAB9A | |
| SCHEMBL12979901 | 0.86 | MAPT (0.73) | MAPTMEN1KMT2AKDM4ERAB9A | |
| SCHEMBL12645167 | 0.86 | MAPT (0.68) | MAPTMEN1KMT2AKDM4ERAB9A | |
| SCHEMBL2246115 | 0.85 | MAPT (1.00) | MAPTMEN1KMT2AKDM4ERAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4707297-A | Removable guidepath for automated guidance vehicles | BELL & HOWELL COMPANY (US) | 1987-11-17 | — | — | US | claimed |
| US-20150150852-A1 | TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS | SIGA TECHNOLOGIES, INC. (US) | 2015-06-04 | — | — | US | disclosed |
| US-20150150852-A1 | TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS | SIGA TECHNOLOGIES, INC. (US) | 2015-06-04 | — | — | US | disclosed |
| US-8993604-B2 | Treatment and prevention of dengue virus infections | SIGA TECHNOLOGIES, INC. (US) | 2015-03-31 | — | — | US | disclosed |
| US-8993604-B2 | Treatment and prevention of dengue virus infections | SIGA TECHNOLOGIES, INC. (US) | 2015-03-31 | — | — | US | disclosed |
| US-20120258079-A1 | Treatment and Prevention of Dengue Virus Infections | SIGA TECHNOLOGIES, INC. | 2012-10-11 | — | — | US | disclosed |
| US-20120258079-A1 | Treatment and Prevention of Dengue Virus Infections | SIGA TECHNOLOGIES, INC. | 2012-10-11 | — | — | US | disclosed |
| US-8283015-B2 | Authenticatable articles and methods therefor | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2012-10-09 | — | — | US | disclosed |
| US-8283015-B2 | Authenticatable articles and methods therefor | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2012-10-09 | — | — | US | disclosed |
| US-8283015-B2 | Authenticatable articles and methods therefor | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2012-10-09 | — | — | US | disclosed |
| US-20080081210-A1 | AUTHENTICATABLE ARTICLES AND METHODS THEREFOR | GENERAL ELECTRIC COMPANY (US) | 2008-04-03 | — | — | US | disclosed |
| US-20080081210-A1 | AUTHENTICATABLE ARTICLES AND METHODS THEREFOR | GENERAL ELECTRIC COMPANY (US) | 2008-04-03 | — | — | US | disclosed |
| US-20080081210-A1 | AUTHENTICATABLE ARTICLES AND METHODS THEREFOR | GENERAL ELECTRIC COMPANY (US) | 2008-04-03 | — | — | US | disclosed |
| WO-2008039587-A1 | AUTHENTICATABLE POLYMER ARTICLES COMPRISING BENZOXAZOLE AND BENZOTHIAZOLE AUTHENTICATION COMPOUNDS | GENERAL ELECTRIC COMPANY (US) | 2008-04-03 | — | — | WO | disclosed |
| EP-1162936-A4 | BODY COATING COMPOSITION | PYRAMID PRODUCTIONS INC (US) | 2006-01-04 | — | — | EP | disclosed |
| US-6582684-B1 | A fluorescent and/or phosphorescent coating composition, particularly useful as a body coating, hair coating, lipstick and particularly as a phosphorescent nail polish that has the capability of changing from transparent, or other color, in | XSIGHT INTERNATIONAL | 2003-06-24 | — | — | US | disclosed |
| EP-1162936-A1 | BODY COATING COMPOSITION | Pyramid Productions Inc. (US) | 2001-12-19 | — | — | EP | disclosed |
| WO-2000056274-A1 | BODY COATING COMPOSITION | PYRAMID PRODUCTIONS, INC. (US) | 2000-09-28 | — | — | WO | disclosed |
| US-5896297-A | Robotube delivery system | VALERINO SR FRED M (US) | 1999-04-20 | — | — | US | disclosed |
| US-4707297-A | Removable guidepath for automated guidance vehicles | BELL & HOWELL COMPANY (US) | 1987-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150150852-A1 | TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS | HAVCR2, TTPA, CHIA | MAPT 118/4885MEN1 4028/4885KMT2A 1695/4885 |
| US-20120258079-A1 | Treatment and Prevention of Dengue Virus Infections | HAVCR2, TTPA, CHIA | MAPT 118/4885MEN1 4028/4885KMT2A 1695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.